Creating a successful advanced market commitment for neonatal sepsis diagnostics takes more than funding. In the final part of series from Center for Global Development & Market Shaping Accelerator (MSA), experts set out how the new working group intends to make the AMC happen: bit.ly/4nkKXzE

The push for universal vaccines is right, but the US risks falling short by betting on a single tech platform. Christopher Snyder & Sebastian Quaade urge HHS.gov to diversify under Generation Gold Standard. 💉 Read more: bit.ly/45n1Wep

MSA convened leading experts from economics, clinical care, policy, and industry for the first Center for Global Development NeoTest Working Group meeting. The group will develop market based incentives to accelerate rapid diagnostic innovation for neonatal sepsis in low- and middle-income countries.

CARB-X Executive Director Kevin Outterson joined a working group convened by Center for Global Development and Market Shaping Accelerator (MSA) that aims to develop an advance market commitment for a rapid diagnostic test for neonatal sepsis in LMICs. 🔗 Read here: bit.ly/44ku4xJ

Neonatal sepsis causes up to 700k anual newborn deaths. A rapid diagnostic could save lives & curb AMR. Center for Global Development & Market Shaping Accelerator (MSA) propose a new approach: using an advance market commitment to incentivize the development of rapid diagnostic tests. More ⬇️ bit.ly/4leKCwA